Aziz Ansari, an award-winning actor, director, writer and comedian, brings his “Hypothetical Tour” to the Gallo Center. He co ...

Vertex Pharmaceuticals Incorporated’s VRTX third-quarter 2025 results were strong as it beat estimates for both earnings and ...

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of ...

Cathie Wood's ARK Invest bought $17M in CRISPR and Beam gene-editing stocks while selling Teradyne, Roku, and SoFi shares on ...

Genetically modified organisms, also known as GMOs, have been a hot topic of conversation among researchers, producers, ...

A poorly characterized protein, historically thought to be a chaperone or enzyme, may actually be a key player in prostate ...

A poorly characterized protein, historically thought to be a chaperon or enzyme, may actually be a key player in prostate ...

NEW YORK – Azalea Therapeutics launched on Tuesday, having raised $82 million in seed and Series A financing to develop in vivo genetic medicines for cancer and autoimmune conditions using its ...

Smith, a microbiologist whose discovery revolutionize the field of genetic engineering, was a Johns Hopkins School of ...

The grantmaking organization Open Philanthropy has awarded funding for a University of California San Diego technology ...

T cell therapies have revolutionized cancer treatment—but so far, their success has been largely limited to blood cancers. Solid tumors, which account for around 90% of all adult cancers, remain a ...

Learn why research that continues to look for new substrate alternatives is essential to the future of growing.